ALK5 Inhibition of Subconjunctival Scarring From Glaucoma Surgery: Effects of SB-431542 Compared to Mitomycin C in Human Tenon's Capsule Fibroblasts
Translational Vision Science & Technology · 2023
DOI: 10.1167/tvst.12.2.31 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Vision Science & Technology, 2023. Verfasst von Jack E Teplitsky und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada. Hauptthemen laut MEDLINE: Mitomycin, Glaucoma. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Purpose
The gold standard for managing postoperative ocular fibrosis in glaucoma surgery is the chemotherapeutic mitomycin C (MMC) despite its association with significant adverse effects. This study compares in vitro the antifibrotic efficacy and cytotoxicity of the small-molecule TGFβ1 inhibitor SB-431542 (SB) to MMC.
Methods
To measure collagen contraction, human Tenon's capsule fibroblasts (HTCFs) embedded in a three-dimensional collagen lattice were exposed to 0.2 mg/mL MMC or 20 µM SB followed by incubation with 2 ng/mL TGFβ1. Total protein extracted from experimentally treated HTCFs underwent immunoblotting for α-smooth muscle actin (α-SMA), matrix metallopeptidase 9 (MMP-9), and EDA splice-variant fibronectin (EDA-FN) expression. Cytotoxicity and cell metabolism were assessed using LIVE/DEAD staining, lactate dehydrogenase (LDH) assay, and methylthiazole tetrazolium (MTT) assay.
Results
Collagen lattice contraction in TGFβ1-induced HTCFs was significantly lowered by SB and MMC. Pretreatment with SB and MMC significantly lowered protein expression of α-SMA, MMP-9, and EDA-FN in HTCFs relative to TGFβ1 alone. HTCF viability in collagen lattices was significantly reduced with MMC pretreatment but not SB pretreatment. MMC-pretreated HTCFs had a significant increase in LDH release after 3 hours and a decrease in MTT activity after 20 minutes, while SB-pretreated HTCFs showed no significant changes via MTT or LDH assay during the same treatment period.
Conclusions
SB shows comparable efficacy to MMC in reducing expression of fibrosis-promoting proteins in HTCFs and in vitro scarring activity. SB distinguishes itself from MMC by exhibiting less cytotoxicity in both two-dimensional and three-dimensional in vitro assays. Translational Relevance: This study demonstrates in vitro the potential of SB as a safer alternative ocular antifibrotic agent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Laboratory Medicine, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada.
- Department of Ophthalmology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada.
- Ivey Eye Institute, St. Joseph's Health Care, London, Ontario, Canada.
- Department of Ophthalmology, University of Ottawa, Ottawa, Ontario, Canada.
- Lawson Health Research Institute, London, Ontario, Canada.
Zitieren
APA
Teplitsky, J. E., Vinokurtseva, A., Armstrong, J. J., Denstedt, J., Liu, H., & Hutnik, C. M. L. (2023). ALK5 Inhibition of Subconjunctival Scarring From Glaucoma Surgery: Effects of SB-431542 Compared to Mitomycin C in Human Tenon's Capsule Fibroblasts. Translational Vision Science & Technology. https://doi.org/10.1167/tvst.12.2.31
Vancouver
Teplitsky JE, Vinokurtseva A, Armstrong JJ, Denstedt J, Liu H, Hutnik CML. ALK5 Inhibition of Subconjunctival Scarring From Glaucoma Surgery: Effects of SB-431542 Compared to Mitomycin C in Human Tenon's Capsule Fibroblasts. Translational Vision Science & Technology. 2023. doi:10.1167/tvst.12.2.31
BibTeX
@article{Teplitsky2023,
author = {Teplitsky, Jack E and Vinokurtseva, Anastasiya and Armstrong, James J and Denstedt, James and Liu, Hong and Hutnik, Cindy M L},
title = {ALK5 Inhibition of Subconjunctival Scarring From Glaucoma Surgery: Effects of SB-431542 Compared to Mitomycin C in Human Tenon's Capsule Fibroblasts},
journal = {Translational Vision Science & Technology},
year = {2023},
doi = {10.1167/tvst.12.2.31}
}
EUVIMED